Inhibition of ice recrystallization during cryopreservation of cord blood grafts improves platelet engraftment
- 18 March 2020
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 60 (4) , 769-778
Abstract
BACKGROUND: Platelet engraftment following cord blood (CB) transplantation remains a significant hurdle to this day. The uncontrolled growth of ice, a process referred to as ice recrystallization, is one of several mechanisms that lead to cell loss and decreased potency during freezing and thawing. We hypothesized that reducing cell damage induced by ice recrystallization in CB units (CBUs) would reduce losses of stem and progenitor cells and therefore improve engraftment. We previously demonstrated that the ice recrystallization inhibitor (IRI) N‐(2‐fluorophenyl)‐D‐gluconamide (IRI 2) increases the postthaw recovery of CB progenitors. Herein, we set out to ascertain whether IRI 2 can enhance platelet and bone marrow engraftment activity of hematopoietic stem cells (HSCs) in cryopreserved CBUs using a serial transplantation model.STUDY DESIGN AND METHODS: CBUs were processed following standard volume/red blood cell reduction procedure and portions frozen with dimethyl sulfoxide (DMSO) supplemented or not with IRI 2. Thawed CB samples were serially transplanted into immunodeficient mice.RESULTS: Our results show that supplementation of DMSO with IRI 2 had several beneficial effects. Specifically, higher levels of human platelets were observed in the peripheral blood (p < 0.05; n = 4) upon transplant of CBUs preserved with the IRIs. In addition, human BM chimerism and the number of human CFU progenitors in the bone marrow were superior in IRI 2 recipients compared to DMSO recipients. Moreover, IRI 2 had no negative impact on the multilineage differentiation and self‐renewal activities of HSCs.DISCUSSION: Taken together, these results demonstrate that supplementation of a hematopoietic graft with IRI can improve the postthaw engraftment activities of HSCs.Keywords
Funding Information
- Canadian Institutes of Health Research (RN313059)
- Canadian Glycomics Network
This publication has 34 references indexed in Scilit:
- The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemiaBlood Advances, 2019
- Glycerol-Free Cryopreservation of Red Blood Cells Enabled by Ice-Recrystallization-Inhibiting PolymersACS Biomaterials Science & Engineering, 2015
- Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftmentTransfusion, 2011
- Inhibiting ice recrystallization and optimization of cell viability after cryopreservationGlycobiology, 2011
- Early apoptosis in CD34+ cells as a potential heterogeneity in quality of cryopreserved umbilical cord bloodBritish Journal of Haematology, 2006
- Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral bloodCryobiology, 2005
- Supplementation of Conventional Freezing Medium with a Combination of Catalase and Trehalose Results in Better Protection of Surface Molecules and Functionality of Hematopoietic CellsJournal of Hematotherapy & Stem Cell Research, 2003
- Cryopreservation of umbilical cord blood: 1. Osmotically inactive volume, hydraulic conductivity and permeability of CD34+ cells to dimethyl sulphoxideCryobiology, 2003
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989
- Ice Recrystallization in Frozen BeefJournal of Food Science, 1982